Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$1.19 USD
-0.02 (-1.65%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.20 +0.01 (0.84%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth NA Momentum NA VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TRIB 1.19 -0.02(-1.65%)
Will TRIB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TRIB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TRIB
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial
TRIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Trinity Biotech's Stock Rises After Acquisition of Metabolomics
Other News for TRIB
Is TRIB about to break its pattern? Narrow Range Bar shows up after sinking 1.65%
TRIB forms MACD Bullish Signal Line Cross on September 18
Is TRIB primed for volatility? Narrow Range Bar shows up after sinking 1.67%
Is TRIB getting ready to pop? Narrow Range Bar shows up after gaining 0.84%
TRIB forms NR7 on September 15